In summary, by systematically investigating the cellular features of MM cells, here we found that CD38 overexpression affects the energetic status of these cells by shifting mitochondria dynamics and triggering oxidative stress, thus priming the activity of NAD+-lowering agents. This evidence concerns the gene CD38 and Miyoshi myopathy.